Intrinsiqs

Is Olema Pharmaceuticals, Inc. overvalued?

Olema Pharmaceuticals, Inc. (OLMA) — key valuation metrics and fundamentals.

No verdict
Price
$8.61
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$752.1M
Dividend yield
0.0%
Return on equity
-48.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares OLMA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.